Home › Anastomotic Leak › NCT07351071
Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
A Prospective, Multicenter, Single-arm, Post Market Study to Evaluate the Safety and Performance of the Signia™ Circular Stapler With Tri-Staple™ Technology in Elective Open or Minimally Invasive Left-sided Colon, Sigmoid, and Rectal Resections (SECURE)
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Preoperative Inclusion Criteria: 1. Subject is competent and willing to provide documented informed consent to participate in this clinical study 2. Subject is intended to undergo an elective left sided colon/colorectal procedure where a creation of an anastomosis will be completed with the Signia™ circular stapler 3. Subject is ≥ 18 years of age at time of consent Preoperative Exclusion Criteria: 1. Subject is unable or unwilling to comply with the study requirements or follow-up schedule 2. Subject with ASA classification ≥ IV 3. Subject is pregnant (as determined by standard site practices) 4. The procedure is an emergency procedure 5. The procedure is a revision/reoperation for the same indication 6. The subject has a documented confounding medical condition which in the opinion of the investigator, will not be appropriate for the study, or the subject has an estimated life expectancy of less than 6 months 7. Subject has participated or plans to participate in an investigational drug or device research study that would interfere with the results of this study 8. Subject will undergo multiple synchronous colon resections 9. Subject with a bleeding disorder or is undergoing anticoagulant treatment that has not been reversed (anticoagulant prophylaxis prescribed as part of the surgical protocol is allowed) 10. Subject has undergone chemotherapy or received biologics within 6 weeks prior to the day of the procedure 11. Subject has history of chronic corticosteroid use (used greater than 3 months within a year prior to the index procedure) 12. Subject has chronic immunosuppression therapy (used greater than 3 months within a year prior to the index procedure) 13. Any subject undergoing an ileal-anal pouch anastomosis surgery Intraoperative Exclusion Criteria 1. Anastomosis not attempted with the Signia™ circular stapler 2. Any subject for which the device is intended to be used outside the instructions for use (IFU)
About the study
The purpose of this study is to evaluate the safety and performance of the Signia™ power handle, Signia™ circular adapter, and Signia™ Tri-Staple™ 2.0 circular reloads (hereafter referred to as Signia™ circular stapler) in patients undergoing left sided colon, sigmoid, or rectal resections in a post market setting.
What is being tested
- Signia™ circular stapler with Tri-Staple™ Technology (Signia™ Circular Stapling system) (device)
Sponsor: Medtronic - MITG · Participants: 137 · Started: Dec 30, 2025
Contact the study team
- Yeshareg Yismaw · Phone: +7635050079
Official record on ClinicalTrials.gov — NCT07351071
Locations in the U.S.
| Connecticut | Yale University, New Haven |
| Georgia | Wellstar Hospital, Marietta (Not yet recruiting) |
| Massachusetts | Massachusetts General Hospital, Boston (Not yet recruiting) |
| Minnesota | Mayo Clinic, Rochester (Not yet recruiting) |
| North Carolina | Duke University, Durham |
| Ohio | The Ohio State University Wexner Medical Center, Columbus |
| Pennsylvania | Lankenau Institute for Medical Research, Wynnewood |
| Texas | University of Texas Health Science Center at Houston, Houston |
| Wisconsin | SSM Health St. Mary's Hospital - Madison, Madison |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.